Company news

Sohm, Inc. (OTC:SHMN) news

Sohm, Inc. news releases on 6ix. Latest, Sep 21, 2026: Silver Hammer Announces Uplisting to the OTCQB Venture Market in the United States, and Receives DTC…

Sohm, Inc. (OTC:SHMN) news

Press releases & updates

Silver Hammer Announces Uplisting to the OTCQB Venture Market in the United States, and Receives DTC Eligibility

SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery

SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development

SOHM, Inc. Announces Allowance of Another Divisional Patent in the Republic of South Korea

SOHM, Inc., Moving and Expanding Commercialization Capabilities with its New Vista, CA Facility

SOHM Achieves Breakthrough with ABBIE Gene Editing Platform, Advancing Strategic Partnership and Licensing Opportunities

SOHM, Inc. Launches New User-Friendly Website to Enhance Customer, Investor Experience and Engagement

SOHM, Inc. Appoints Ravi Kapoor as an Independent Director

SOHM, Inc. Sets Strategic Goals to Enter Biotechnology-Driven Cosmeceuticals Market

SOHM Inc. Welcomes Dr. Larissa Karnaoukhova as New Vice President of Operations

SOHM Inc. Welcomes Dr. Lucia Piccotti to Offer Expert Guidance on Cosmeceutical and Personal Health Product Research and Development

SOHM, Inc., Unveils Genetically Engineered Ovarian Cancer Cell Line Using ABBIE(TM) Platform to Accelerate GYS1 Drug Discovery

Dr. Leonardo Mirandola Joins SOHM, Inc. as an Advisory Board to Advance CAR-T Cell Projects Toward Clinical Trials and Commercialization

SOHM Inc. Awarded European Patent for Innovative ABBIE Genome Editing Technology

SOHM, Inc. Agrees to Licensing for Investigational and Pre-Clinical Studies for Groundbreaking ABBIE Genome Editing Technology for CAR-T Cell Cancer Therapies

SOHM, Inc. Announces Patent Allowance/Approval in South Korea

SOHM, Inc. Shares an Exciting Expansion and Upcoming Presentation on ABBIE

SOHM, Inc. Launches New AI Team to Advance ABBIE System and Genome Editing Innovations

SOHM, Inc. Shares Groundbreaking Findings in ABBIE Technology

SOHM, Inc. Announce Dr. Wei Zhu Onboard as Senior Marketing and Sales Consultant

SOHM, Inc. Announces Allowances Of Japanese Patent Claims Received from Japan's Patent Office (特許庁, Tokkyochō, JPO) Protecting Transformative SOHM-ABBIE Genome Edited, SAGE Recombinant-Organisms, -Cells, -Secretomes, -Exosomes

SOHM, Inc. Announce Dr. David Zarling Onboard as Senior Product Development Advisor

SOHM, Inc. Continues to Build its IP Portfolio in the Gene Editing and Cell Engineering Space

SOHM, Inc. has Received ABBIE Technology Kits' Pre-Launch Pre-Orders

SOHM, Inc., Announce Dr. Tetsuya Kawamura Ph. D. Joined as a Cell Engineer and Biochemist

SOHM, Inc. has signed the Manufacturing and Supply of Skincare Topical Products with New Export Customers

SOHM, Inc., Announce a New Collaboration and Joins Forces with Stanford University

SOHM, Inc. Announces its ABBIE Genome Editing Technology Successfully Engineered a T-cell immunotherapy from a Healthy Human Donor

SOHM, Inc., Targets Revolutionary New ABBIE Genome Editing Kits for Q3, 2024

SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers

SOHM Files Provisional Patent on ABBIE’s ‘Smart Gene-Editing’ That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations

SOHM Announces Business Outlook for 2024

SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California

SOHM OTC Self-care Launches Suite of 13 New SOHM Nutrients’ Brand Chewables

SOHM Collaborates with University of Arizona Center for Innovation to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology

SOHM Announces Its Acquisition of ABBIE, a World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors

SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing as VP of Quality with Immediate Effect

SOHM, Inc. Expands Its Advisory Board, Appointing Dr. Krishna Bhat, M.D, Ph.D., FACC, as Chief Medical Advisor

SOHM, Inc. Announce the Appointment of Dr. David Aguilar, Ph.D. as a Chief Operating Officer with the Company with Immediate Effect

SOHM Inc. Signs LOI to Acquire Stem Cell Disruptive Technology and Patents

SOHM Inc. Announces the Closure of Finances-Funding for its Various Projects

SOHM Inc. Signed an Exclusive Distribution Agreement with India-based Stallion Laboratories Pvt. Ltd. for Levetiracetam for the Treatment of Epilepsy

SOHM, Inc. Introduces and Received Topical Skincare Line of Products Orders in Its Label

SOHM, Inc. Signs MOU with London/Asia-Based Fund to Infuse Funds for Various Projects

SOHM, Inc. Expands Advisory Board with Appointment of Dr. David Aguilar Ph.D., as its Expert Medical Advisor.

SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing, former US FDA Investigator to its Advisory Board

SOHM, Inc., Collaborates for Commercial Manufacturing of Brainwise(R), a Patented Omega 3 Formula for Global Distribution

SOHM, Inc. Signs Industry Expert Sivana Group as Strategic Consultant for Rebranding and Global Expansion

SOHM, Inc., Announces Important Details of Its California Pharmaceutical Company Acquisition Expanding Manufacturing into the US Market

SOHM, Inc., Signed a Definitive Agreement for Acquisition of Californian Pharmaceutical Company